Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Cat-PAD in Cat Allergic Subjects With Controlled Asthma
NCT00867906Phase 2Completed
- Sponsor
- NIOX Group
- Start
- Mar 2009
- Primary completion
- Apr 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Cat-PAD in cat allergy, sponsored by NIOX Group. Started Mar 2009; status: completed.
02
Drugs
Cat-PAD
03
Conditions
cat allergy
Beyond the preview
Go deeper on NCT00867906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00867906.